|
Play Video: The Importance of Insider Buying
|
|
|
The table below summarizes the most recent XRAY insider buying information, with links below the price to see the
CAGR achieved by each insider on their purchases. As the saying goes on Wall St., there are many
possible reasons to sell a stock, but only one reason to buy. Watch the importance of insider buying video for more
information about why XRAY insider buys are important for investors to follow.
Date | Insider | Price | Amount |
11-22-2023 Insider Buy |
Gregory T. Lucier Director |
$31.44
CAGR »
|
$314,400.00 10,000 shares |
11-20-2023 Insider Buy |
Simon D. Campion President, CEO & Member of BOD |
$29.70
CAGR »
|
$297,000.00 10,000 shares |
11-20-2023 Insider Buy |
Glenn Coleman Executive VP & CFO |
$29.70
CAGR »
|
$297,000.00 10,000 shares |
11-15-2022 Insider Buy |
Gregory T. Lucier Director |
$31.45
CAGR »
|
$188,700.00 6,000 shares |
12-1-2021 Insider Buy |
Donald M. Casey Jr. President & CEO |
$49.78
CAGR »
|
$995,600.00 20,000 shares |
3-4-2021 Insider Buy |
Gregory T. Lucier Director |
$58.75
CAGR »
|
$528,751.80 9,000 shares |
6-6-2019 Insider Buy |
Betsy D. Holden Director |
$55.31
CAGR »
|
$150,438.85 2,720 shares |
5-29-2019 Insider Buy |
Donald M. Casey Jr. President & CEO |
$53.68
CAGR »
|
$536,769.00 10,000 shares |
5-23-2019 Insider Buy |
Gregory T. Lucier Director |
$53.60
CAGR »
|
$536,047.00 10,000 shares |
5-7-2019 Insider Buy |
Daniel P. Key SVP,Chief Supply Chain Officer |
$54.68
CAGR »
|
$202,151.96 3,697 shares |
5-9-2018 Insider Buy |
Nicholas W. Alexos EVP, CFO |
$44.71
CAGR »
|
$2,235,500.00 50,000 shares |
5-9-2018 Insider Buy |
Donald M. Casey Jr. President & CEO |
$44.52
CAGR »
|
$1,001,720.25 22,500 shares |
11-13-2017 Insider Buy |
Mark Thierer Interim Chief Exec Officer |
$66.04
CAGR »
|
$5,084,741.20 77,000 shares |
11-13-2017 Insider Buy |
Nicholas W. Alexos EVP, CFO |
$65.85
CAGR »
|
$3,292,500.00 50,000 shares |
Also See: Institutional Holders of XRAY
Also See: SEC filings
Below we present the annualized performance delivered by XRAY stock since 11-22-2023 (the date of the most recent
insider purchase). The performance of the investment from the time XRAY insider buying occurred is the ultimate
test of whether insiders were right about XRAY being a good buy.
Growth of $10,000.00
With Dividends Reinvested
|
Start date: |
11/24/2023 |
|
End date: |
04/18/2024 |
|
Start price/share: |
$31.32 |
|
End price/share: |
$30.44 |
|
Starting shares: |
319.28 |
|
Ending shares: |
322.08 |
|
Dividends reinvested/share: |
$0.30 |
|
Total return: |
-1.96% |
|
Annualized Gain: |
-4.93% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$9,804.00 |
|
Years: |
0.40 |
|
|
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
11/24/2023 |
|
End date: |
04/18/2024 |
|
Start price/share: |
$31.32 |
|
End price/share: |
$30.44 |
|
Dividends collected/share: |
$0.30 |
|
Total return: |
-1.85% |
|
Annualized Gain: |
-4.66% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$9,815.00 |
|
Years: |
0.40 |
|
XRAY Insider Buying
This Holdings Channel page has presented insider buying activity, covering Directors, officers (such as CEO, CFO, COO, etc.),
and >10% owners (who are required to file form 4's with the SEC). Important institutional owners may not fall under these
categories, but instead file their holdings quarterly on the latest form 13F filings.
While recent XRAY insider buying activity is included, there may also be stock sales over this same period (Also See: SEC filings for sales and other details).
Also See: Funds Holding XRAY
|
|